Bacopa monnieri extract increases rat coronary flow and protects against myocardial ischemia/reperfusion injury

Affiliation auteurs!!!! Error affiliation !!!!
TitreBacopa monnieri extract increases rat coronary flow and protects against myocardial ischemia/reperfusion injury
Type de publicationJournal Article
Year of Publication2017
AuteursSrimachai S, Devaux S, Demougeot C, Kumphune S, Ullrich ND, Niggli E, Ingkaninan K, Kamkaew N, C. Scholfield N, Tapechum S, Chootip K
JournalBMC COMPLEMENTARY AND ALTERNATIVE MEDICINE
Volume17
Pagination117
Date PublishedFEB 20
Type of ArticleArticle
ISSN1472-6882
Mots-clésBacopa monnieri, Brahmi, Cardiac function, Coronary blood flow, Heart, Ischemia/reperfusion, Myocardial infarction
Résumé

Background: This study explored Bacopa monnieri, a medicinal Ayurvedic herb, as a cardioprotectant against ischemia/reperfusion injury using cardiac function and coronary flow as end-points. Methods: In normal isolated rat hearts, coronary flow, left ventricular developed pressure, heart rate, and functional recovery were measured using the Langendorff preparation. Hearts were perfused with either (i) Krebs-Henseleit (normal) solution, (control), or with 30, 100 mu g/ml B. monnieri ethanolic extract (30 min), or (ii) with normal solution or extract for 10 min preceding no-perfusion ischemia (30 min) followed by reperfusion (30 min) with normal solution. Infarct volumes were measured by triphenyltetrazolium staining. L-type Ca2+-currents (I-Ca, L) were measured by whole-cell patching in HL-1 cells, a mouse atrial cardiomyocyte cell line. Cytotoxicity of B. monnieri was assessed in rat isolated ventricular myocytes by trypan blue exclusion. Results: In normally perfused hearts, B. monnieri increased coronary flow by 63 +/- 13% (30 mu g/ml) and 216 +/- 21% (100 mu g/ml), compared to control (5 +/- 3%) (n = 8-10, p < 0.001). B. monnieri treatment preceding ischemia/reperfusion improved left ventricular developed pressure by 84 +/- 10% (30 mu g/ml), 82 +/- 10% (100 mu g/ml) and 52 +/- 6% (control) compared to pre-ischemia/reperfusion. Similarly, functional recovery showed a sustained increase. Moreover, B. monnieri (100 mu g/ml) reduced the percentage of infarct size from 51 +/- 2% (control) to 25 +/- 2% (n = 6-8, p < 0.0001). B. monnieri (100 mu g/ml) reduced ICa, L by 63 +/- 4% in HL-1 cells. Ventricular myocyte survival decreased at higher concentrations (50-1000 mu g/ml) B. monnieri. Conclusions: B. monnieri improves myocardial function following ischemia/reperfusion injury through recovery of coronary blood flow, contractile force and decrease in infarct size. Thus this may lead to a novel cardioprotectant strategy.

DOI10.1186/s12906-017-1637-z